Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 07, 2023

SELL
$174.31 - $239.52 $871 - $1,197
-5 Closed
0 $0
Q2 2022

Nov 07, 2023

BUY
$130.2 - $168.03 $651 - $840
5 New
5 $748,000
Q1 2022

Nov 07, 2023

SELL
$138.87 - $214.31 $416 - $642
-3 Closed
0 $0
Q4 2021

Nov 07, 2023

BUY
$182.74 - $227.9 $548 - $683
3 New
3 $653,000
Q3 2020

Nov 07, 2023

SELL
$92.95 - $130.61 $44,151 - $62,039
-475 Closed
0 $0
Q1 2020

Nov 07, 2023

BUY
$61.71 - $101.95 $8,269 - $13,661
134 Added 39.3%
475 $34.9 Million
Q3 2019

Nov 07, 2023

BUY
$62.38 - $85.89 $14,347 - $19,754
230 Added 207.21%
341 $28.7 Million
Q2 2019

Nov 06, 2023

SELL
$53.64 - $65.42 $4,773 - $5,822
-89 Reduced 44.5%
111 $7.26 Million
Q1 2019

Nov 06, 2023

BUY
$49.38 - $70.58 $9,876 - $14,116
200 New
200 $11.8 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.